Kwang Dong Pharmaceutical Co., Ltd. (KOSE:A009290) agreed to acquire a 58.73% stake in BL Healthcare Corp. (XKON:A086220) from BL Healthcare Corp. (XKON:A086220) for KRW 30 billion on December 29, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,685 KRW | -3.59% | +2.48% | -0.56% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,780 KRW | +0.44% | +2.26% | 197M | ||
2,685 KRW | -3.59% | +2.48% | 20.63M | ||
485 KRW | -1.62% | +3.19% | 31.35M | ||
1st Jan change | Capi. | |
---|---|---|
-0.56% | 20.63M | |
+8.20% | 7.78B | |
+0.34% | 7.38B | |
+10.20% | 6.52B | |
-8.10% | 3.67B | |
-14.57% | 1.17B | |
+8.34% | 934M | |
-42.27% | 879M | |
-18.90% | 836M | |
-16.45% | 802M |
- Stock Market
- Equities
- A086220 Stock
- News Kwangdong Healthbio Co., Ltd.
- Kwang Dong Pharmaceutical Co., Ltd. agreed to acquire a 58.73% stake in BL Healthcare Corp. from BL Healthcare Corp. for KRW 30 billion